camptothecin has been researched along with deoxyguanosine in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Johnson, RT; Ryan, AJ; Smith, PJ; Squires, S; Strutt, HL | 1 |
| Burke, TG; Curran, DP; Du, W; Jerina, DM; Kohlhagen, G; Laco, GS; Pommier, Y; Sayer, JM | 1 |
| Antony, S; Brooks, PJ; Lesher, DT; Pommier, Y; Redinbo, M; Theruvathu, JA | 1 |
| Haruna, K; Hatta, H; Ito, T; Nishimoto, S; Zhang, Z | 1 |
4 other study(ies) available for camptothecin and deoxyguanosine
| Article | Year |
|---|---|
Deoxyguanosine enhances the cytotoxicity of the topoisomerase I inhibitor camptothecin by reducing the repair of double-strand breaks induced in replicating DNA.
Topics: Camptothecin; Cell Cycle; Cell Line; Cell Survival; Deoxyguanosine; DNA Repair; DNA Replication; Drug Interactions; Humans; RNA; Teniposide; Topoisomerase I Inhibitors | 1991 |
Analysis of human topoisomerase I inhibition and interaction with the cleavage site +1 deoxyguanosine, via in vitro experiments and molecular modeling studies.
Topics: Binding Sites; Camptothecin; Deoxyguanosine; DNA; DNA Topoisomerases, Type I; Humans; Hydrophobic and Hydrophilic Interactions; Ligands; Models, Molecular; Nucleic Acid Conformation; Protein Binding; Static Electricity; Thermodynamics; Topoisomerase I Inhibitors | 2004 |
Enhancement of camptothecin-induced topoisomerase I cleavage complexes by the acetaldehyde adduct N2-ethyl-2'-deoxyguanosine.
Topics: Camptothecin; Deoxyguanosine; DNA; DNA Adducts; DNA Topoisomerases, Type I; Enzyme Inhibitors; Macromolecular Substances; Models, Molecular | 2004 |
Development of novel oxygen-independent photosensitizers.
Topics: Alkylation; Anaerobiosis; Camptothecin; Deoxyguanosine; Furans; Oxidation-Reduction; Photosensitizing Agents; Quinones; Ultraviolet Rays | 2007 |